Introduction
Psoriasis is a chronic immune-mediated inflammatory disease with a polygenic and multi-factorial background. Psoriasis is a common disease worldwide, but several clinical findings indicate differences between Asian and western patients with psoriasis. First, the incidence of psoriasis is lower in Asians (0Á3-1Á2% in China) compared to the western population (2Á5-3Á6% in Caucasians) [1] [2] [3] . Secondly, the severe large plaque type of psoriasis is predominant in western people, while the small plaque type is predominant in Asians [4] . Thirdly, the frequency of comorbidity of psoriatic arthritis is much lower in Asian (1-9%) than in western patients (6-42%) [5] . These data suggest that genetic differences might exist between Asian and western patients with psoriasis.
Advances have been made in understanding the genetic basis of psoriasis through genomewide association studies (GWAS): so far, more than 40 genetic loci have been identified as psoriasis susceptibility genes [6, 7] , including the human leucocyte antigen-C (HLA-C), genes belonging to the interleukin (IL)223/T helper type 17 cell (Th17) axis and those belonging to the nuclear factor kappa B (NFjB) pathway [8] . However, many genetic studies have been performed in western patients, while only a few have been conducted in Asian patients, and the genetic susceptibility of the recently unveiled pathomechanism in the Th17 signal transduction pathway is not yet understood fully.
Understanding of pathogenesis of psoriasis has evolved considerably. The Th17 cell response is promoted by Toll-like receptor (TLR)-induced cytokines of the innate immunity [9] . Recent studies have shown that cathelicidin peptide LL-37 is able to break innate tolerance to selfnucleic acids and activate innate immune cells. In psoriasis, self-nucleic acid gains access to intracellular Toll-like receptors (TLR)27 and 29 when complexed with endogenous LL-37 to trigger high levels of type I interferons (IFNs) in plasmacytoid dendritic cells [10, 11] . LL-37 is found to be over-expressed in psoriatic skin lesion and is suggested as a T cell autoantigen in psoriasis [12] .
Activated macrophages and dendritic cells produce interleukin (IL-23) and differentiate naive CD4
1 T cells into a novel subset, the Th17 cells [13] . Several important cytokines involved in the psoriasis inflammatory cascade, such as IL-6, IL-12 and IL-23, signal through the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway [14] . In this pathway, cytokine receptors recruit two members of the JAK family (JAK1, JAK2, JAK3 or tyrosine kinase 2) into a signalling complex. In particular, in Th17 cells, the IL-23 receptor recruits JAK2 and tyrosine kinase 2 (TYK2) activating STAT-3 sequentially [15, 16] . Th17 cells produce IL-17A, IL-17F and IL-22, which are responsible for the formation of psoriatic plaques [13] . IL-17A and IL-17F signal through the heterodimeric IL-17 receptor (IL-17R) complex in keratinocytes, which consists of IL-17RA and IL-17RC subunits [17] . Previous genetic studies have revealed psoriasis-associated high-risk single nucleotide polymorphisms (SNPs) in IL-23 signalling as IL12B, IL23A and IL23R, while the specific genes encoding molecules in the Th17 cell signal transduction pathway remain to be identified. A growing body of evidence suggests the importance of Th17 cells and the related signal transduction pathway. The psoriasis susceptibility genetic polymorphism of IL23R was reported initially in Crohn's disease (CD) [18] . Both psoriasis and CD are autoimmune diseases, and CD shares pathophysiological mechanisms with psoriasis; psoriasis is five times more common in patients with CD than in controls [19] , and anti-tumour necrosis factor (anti-TNF) drugs are effective in both disorders [20] . To investigate the genetic susceptibility of genes in the Th17 cell signal transduction pathway, we searched for SNP candidates that were studied in inflammatory bowel disease (IBD) or other autoimmune diseases. In this preliminary study, we selected 31 SNPs in the human cathelicidin anti-microbial peptide (CAMP), TLR7, TLR9, IL17A, IL17F, IL17R and IL22 genes (as well as genes involved in the JAK/STAT pathway), evaluated the association of candidate genes with psoriasis and performed linkage disequilibrium (LD) analysis.
Material and methods

Subjects
After an examination by expert dermatologists, 208 psoriatic patients with plaque type psoriasis (129 males and 79 females; mean age 5 42Á5 and standard deviation 5 15Á7) were recruited from the Dermatology Department of the Konkuk University Hospital. Psoriatic patients were diagnosed based on clinical and histopathological criteria [21] . The mean age of onset was 32Á1 6 16Á4 and the psoriasis area and severity index (PASI) was 10Á1 6 6Á4. A total of 266 healthy controls were recruited in the health-care centre of the Konkuk University Hospital (154 males and 112 females; mean age 5 40Á3 years and standard deviation 5 12 years). No gender or age differences existed between the psoriasis and control groups (P-values were 0Á45 and 0Á.097 for gender and age, respectively). We obtained written, informed consent from all patients and control subjects. This study was approved by the institutional review board of the Konkuk University Hospital, Seoul, Korea, and conducted according to the ethical principles of the Declaration of Helsinki.
SNP selection and genotyping analysis
In total, 31 SNPs in IL17A, IL17F, IL17R, IL22, JAK1, JAK2, JAK3, TYK2, STAT3, TLR7, TLR9 and CAMP were selected from studies that investigated the genetic polymorphisms in the IBD or other autoimmune diseases: IL17A (rs2275913, rs3819025, rs3804513 and rs3748067), IL17F (rs763780 and rs2397084), IL17RA (rs6518660, rs2241046, rs2241049, rs879574 and rs882643), IL22 (rs2227483, rs12307915 and rs2227473), JAK1 (rs310241 and rs2780889), JAK2 (rs2274471, rs7849191 and rs10974944), JAK3 (rs3008), TYK2 (rs34536443, rs280519 and rs2304256), STAT3 (rs744166, rs4796793 and rs989119), TLR7 (rs179008 and rs3853839), TLR9 (rs352140 and rs187084) and CAMP (rs9844812).
Genomic DNA was isolated from peripheral blood leucocytes and genotyped using a complete polymerase chain reaction (PCR) reagent set (Sequenom, San Diego, CA, USA). PCR conditions and subsequent detection were performed according to the manufacturer's instructions. Genotyping was performed using MassARRAY iPLEX Gold SNP Genotyping (Sequenom). For quality control, we excluded samples with genotyping call rates < 95%, a minor allele frequency (MAF) < 0Á05 and/or significant deviation from Hardy-Weinberg equilibrium (HWE) in the controls. Eight SNPs with MAF < 0Á05 were excluded for analysis. No significant deviations from the HWE were observed for the SNPs in controls included in this study (P > 0Á05), except for two SNPs (IL17F rs2397084 and TLR7 rs3853839). IL17F rs2397084 is one of the SNPs with a MAF of < 0Á05. In total, 22 SNPs were included (Supporting information, Table S1 ).
Statistical analysis
All gene variants were tested for HWE in the control population. Odds ratios (ORs) were calculated for the minor allele at each SNP. In multiple logistic regression analyses, we used multiple inheritance models, including additive (major allele homozygotes versus heterozygotes versus minor allele homozygotes), dominant (major allele homozygotes versus minor allele homozygotes 1 heterozygotes) and recessive (major allele homozygotes 1 heterozygotes versus minor allele homozygotes) models. Haplotypes were calculated with PHASE software [22] . Clinical characteristics were compared with the Wilcoxon rank-sum test and the v 2 test or Fisher's exact test using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). P < 0Á05 was considered statistically significant.
Results
Allele frequency analysis
Differences in minor allele frequency were not found in any SNPs. Only IL17F SNP rs763780 [OR 5 1Á44, 95% confidence interval (CI) 5 0Á98-2Á13, P 5 0Á06] and JAK2 SNP rs7849191 (OR 5 0Á77, 95% CI 5 0Á59-1Á00, P 5 0Á05) were just close to the threshold of statistical significance (Supporting information, Table S1 ).
Genotype analysis
Genotype distributions for each SNP in the case-control sample are presented in Supporting information, Table S2 . We observed a strong association of two SNPs in IL17F and JAK2 genes with psoriasis. The IL17F rs763780, a missense mutation of T/C on chromosome 6, showed a more than threefold increased prevalence in patients with psoriasis in the recessive model (OR 5 3Á27, 95% CI 5 1Á01-10Á58, P 5 0Á04). In addition, the JAK2 rs2274471 A/G, located in the intron of chromosome 9, was associated strongly with psoriasis in the recessive model (OR 5 2Á66, 95% CI 5 1Á12-6Á35, P 5 0Á02). Notably, the JAK2 rs7849191 C/ T showed a trend of protective effect with a significant threshold (OR 5 0Á77, 95% CI 5 0Á59-1Á01, P 5 0Á05). This means that CC/CT/TT decreased the risk of psoriasis by 0Á77-fold in additive manner. The significant results of this analysis, along with the number of patients of each genotype, are presented in Table 1 .
Haplotype analysis
We measured the LD patterns of the SNPs and identified five LD blocks in all of the loci included in this study (Fig. 1) . Then, we performed haplotype analysis among genetic loci that formed LD blocks. We found significant results only in the haplotype analysis of JAK1 (Table 2 and Supporting information, Fig. S1 ). The JAK1 haplotype ht2, with a frequency of 0Á300 and consisting of wild-types of two SNPs (the AT haplotype of rs310241 and rs2780889), showed a protective effect in the additive model (OR 5 0Á73, 95% CI 5 0Á55-0Á98, P 5 0Á03), indicating that AT haplotype of JAK1 decreased the risk of psoriasis by 0Á73-fold. Other haplotype analyses of individual genes did not yield any significant results.
Clinical associations
We analysed the clinical characteristics of sex, age of onset, PASI, family history of psoriasis, comorbidity of psoriatic arthritis and early-onset psoriasis (under the age of 40 years). The frequency of family history of psoriasis was 16Á4% (25 of 152), while the frequency of psoriatic arthritis was 8Á2% (14 of 170). Early-onset psoriasis patients made up 67% (128 of 191) of all patients with psoriasis. We did not find any significant relationship between the SNPs of IL17F rs763780 and JAK2 rs2274471 and these clinical characteristics. However, the JAK2 rs7849191, which presented a decreased risk of psoriasis in allele and genotype analysis, also showed a trend towards a negative association with the development of early-onset psoriasis (P 5 0Á07), i.e. patients with the protective JAK2 allele rs7849191 tend to develop psoriasis at late age. We did not find any significant relationship between the JAK2 rs7849191 and the other clinical characteristics (Table 3) .
Discussion
We identified two psoriasis susceptibility genes, IL17F and JAK2, in the Korean population. Our results suggest that, for rs763780 of IL17F, which induces a histidine-toarginine substitution at 161 amino acids (His161Arg), homozygous carriers of the CC genotype had an approximately 3Á27-fold increased risk for psoriasis, while for rs2274471 of JAK2 intron polymorphism, homozygous carriers of GG genotype had a 2Á66-fold increased risk for psoriasis when compared with controls. In addition, rs7849191 of JAK2 C/T decreased the risk of psoriasis by 0Á77-fold in an additive manner with statistical threshold and was correlated inversely with the development of early-onset psoriasis (under the age of 40 years). This means that patients with this protective allele tend to develop late-onset psoriasis aged more than 40 years. In the haplotype analysis, a common haplotype of JAK1 rs31024 A/rs2780889T was identified as protective.
We found that the rs763780 T/C polymorphism of IL17F is associated strongly with psoriasis. rs763780, a 7488T/C genetic polymorphism in the third exon of IL17F, is a missense mutation leading to His161Arg and has been studied widely in various immune diseases. Notably, the frequency of the 7488C variant is higher in controls of Asians (Japanese 11Á1% and Chinese 15Á8%) compared to those of Europeans (3Á2-3Á8%), indicating an ethnic difference in this SNP [23] [24] [25] [26] . This genetic polymorphism has been studied in Asian patients with IBD. In a recent study of a New SNPs in the Th17 pathway for psoriasis Chinese population with IBD, the 7488C variant was significantly more common in patients with CD, indicating an increased risk for the development of CD [27] . Conversely, in ulcerative colitis (UC) the 7488T allele was an independent risk factor for the developing UC in Japanese patients and the 7488C variant conferred a protective effect for the development of UC in Chinese patients [24, 28] . In rheumatoid arthritis, the polymorphism was not associated with disease susceptibility, while the disease activity parameters were correlated in the Polish population [25] . In a functional study using recombinant wild-type and mutant IL-17F proteins, the 7488C variant failed to induce proinflammatory cytokines and chemokines and antagonize the activity of wild-type IL-17F in bronchial epithelial cells, confirming that the 7488C variant exerts a protective effect in asthma [23] . Overall, the 7488T/C polymorphism seems to be involved significantly in the development of many inflammatory diseases, but the difference in risk or protective effects in various diseases in different populations requires further investigation.
Rs763780 T/C of polymorphism of IL17F was studied previously in Japanese patients with psoriasis, but no association was found [29] . Very recently, rs763780 of IL17F was studied in response to biologicals in psoriasis patients [30] . Patients carrying the C allele were more likely to be non-responders when treated with adalimumab and ustekinumab, while more likely to be better responders when treated with infliximab. However, further studies with larger samples are required. Functional studies of the cytokine and mRNA induction and change of the activity of this 7488 T/C polymorphism in the inflammatory process in the pathogenesis of psoriasis could be intriguing.
Five SNPs in IL17RA were evaluated in this study, but no statistical evidence was found to support their association with psoriasis. IL-17RA belongs to the IL-17R family, and mediates inflammatory signalling by forming an IL-17 receptor complex that interacts with IL-17A and IL-17F [31] .
A number of cytokines involved in psoriasis pathogenesis (e.g. IFN, IL-6, IL-12 and IL-23) utilize the JAK/STAT3 signalling pathway [15] . Recent GWAS studies of psoriasis 
OR 5 odds ratio; CI 5 confidence interval; Values in bold highlight significant results.
found associations with TYK2, JAK2 and STAT3, while JAK2 was also associated with CD [7, 32, 33] . In this study, we found a new SNP rs2274471 A/G in the intron region of JAK2, which has a strong association with psoriasis and increases the risk of psoriasis by 2Á66-fold. This SNP was explored in the context of CD, but no association was found [34] . In addition, rs7849191 C/T polymorphism in the intron region of JAK2 showed an inverse association with psoriasis and met the statistically significant threshold (P 5 0Á05). This rs7849191 C/T polymorphism decreased the risk of psoriasis by 0Á77-fold in an additive manner. Interestingly, in clinical associations, the JAK2 rs7849191 C/T also showed that patients with this protective variant tend to develop psoriasis at a later age (more than 40 years). This clinical association stresses the value of this protective SNP of JAK2. In LD analysis, these two SNPs of JAK were not linked closely and did not form a haplotype block. Further studies are required with larger samples, as well as functional analyses on altering messenger RNA splicing or post-transcriptional processes of this JAK2 intron variant. From the LD and haplotype analysis, we found one common JAK1 haplotype: the rs310241A/rs2780889T associated inversely with psoriasis in the Korean population. With regard to the rs310241 A/G of the intron region of JAK1, the rs310241G variant has been reported to be involved in susceptibility to Behc¸et's disease and Vogt-Koyanagi-Harada syndrome [35, 36] . The JAK1 rs2780889 T/A of the 3' untranslated region (UTR) has been reported in only one study of IBD and systemic lupus erythematosus, but no association has been found. Interestingly, a combination of common alleles, the rs310241A/rs2780889T haplotype, showed a protective effect in psoriasis in this study. These data are novel and have not been reported previously.
The important role of the innate immune response in the pathogenesis of psoriasis has been reported recently. It has been observed frequently in clinics that psoriasis is triggered or exacerbated by upper respiratory tract infections [37] . The Th17 cell response is part of the adaptive immunity, but can be activated by innate immunity. In this study, we screened five SNPs in genes involved in innate immunity: rs179008 and rs3853839 in TLR7, rs187084 and rs352140 in TLR9 and rs9844812 in LL37(CAMP). We found no association between these SNPs and psoriasis.
P-values for the SNP association in this study were not corrected for multiple comparisons. However, this study investigated the association of genetic polymorphisms in the distinct biological pathway, the Th17 cell signalling 
Odds ratios (OR) and their 95% confidence intervals (CI) are for the logistic model for linear trend of association; Values in bold highlight significant results. Table 3 . Clinical associations between IL17F rs763780, JAK2 rs2274471 and JAK2 rs7849191 genotypes and psoriasis characteristics in psoriatic patients pathway. The newly identified SNPs and haplotype in this preliminary study are attractive candidates for future hypothesis-driven investigations of the susceptibility to psoriasis.
In conclusion, we report two psoriasis susceptibility loci: one in 6p12 IL17F rs763780 and the other in 9p24 JAK2 rs2274471, as well as one protective locus rs7849191 in JAK2 and one protective haplotype rs310241A/rs2780889T in JAK1 for psoriasis in the Korean population. In the clinical correlation analysis, patients with the protective JAK2 allele tended to develop late-onset psoriasis. Further studies, including functional experiments, are required to understand more clearly the underlying mechanisms of psoriasis pathogenesis that involve the IL17F and JAK2 genes.
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